Report Description

The global tumor transcriptomics market is anticipated to witness a growth of robust CAGR  in the forecast period, 2023-2027. Factors such as the increased prevalence of chronic diseases and disorders worldwide and growing awareness about the benefits of personalized medicine or precision medicine primarily drive the demand for the global tumor transcriptomics market. Also, the surge in high-end investments for pharmaceutical and biotechnology research and development activities to develop novel transcriptomics products is expected to create numerous growth opportunities for the market players in the next five years.

Growing Demand for Personalized Medicine Drives the Market Growth

Personalized medicine is a customized process to treat diseases according to different individuals and types of disease. This approach includes the identification of epigenomic, genetic, and clinical information, which helps to understand about a human unique genomics portfolio makes them vulnerable to certain diseases. Personalized medicine is a novel and exciting topic in the healthcare industry and has the potential to transform medical interventions by developing therapeutic and effective strategies to cure the disease. Personalized medicine has become the fundamental focus of research in the healthcare industry. It offers several benefits, such as lowering the high-risk invasive testing procedures and directing targeted therapy and reducing trial-and-error prescribing. Personalized medicine shifts the emphasis in medicine from reaction to prevention and reduces the frequency and magnitude of adverse drug reactions. It reveals additional targeted uses for medicines and drug candidates and helps physicians shift from physician-patient engagement toward patient-centered care. The rise in the number of tailored therapies, medications, and diagnostic procedures being performed around the globe is influencing the market demand. Furthermore, the surge in focus on biomarker research and toxicogenomic and the increasing interest in outsourcing services are expected to propel the global tumor transcriptomics market growth in the coming years.

Increased Prevalence of Cancer Supports the Market Growth

Tumor transcriptomics involves technologies that can be used to treat cancer earlier and provide predictive and prognostic information to patients and oncologists. Digital technologies such as tumor transcriptomics are replacing the still-imaging techniques to find the cause of cancer disease. The technology helps healthcare professionals to understand tumor classification and progression. Typically, cancer experiences a number of genetic changes, but only a limited are responsible for tumor progression. Tumor transcriptomics can help determine variants in cancer samples and identify gene expression signatures and mutational profiles associated with individual tumors, single cells, and tumor types. They also aid in focusing on somatic mutations that have a clear functional effect and identifying the key cancer mutation and finding new small RNAs that regulate gene expression. The high prevalence of cancer across the globe and the growing mortality rate due to cancer is expected to fuel the global tumor transcriptomics market growth over the next five years.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The global tumor transcriptomics market is segmented into tumor type, technology, product, application, end user, regional distribution, and competitive landscape. Based on tumor type, the market is divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others. Based on technology, the market is divided into microarray, real-time quantitative, polymerase chain reaction (Q-PCR), and others. Based on product, the market is divided into consumables, instrument, software & services. Based on application, the market is divided into diagnostics and disease profiling, drug discovery, and others. Based on end user, the market is divided into biotechnology & pharmaceutical companies, research & academic institutions, others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to be a lucrative market as it allocates huge funds for the development of the healthcare industry and adopts advanced and novel technologies to improve healthcare services.

Market Players

Thermo Fischer Scientific, Inc., Caris Life Sciences, Inc., Illumina, Inc., NanoString Technologies, Inc., 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Pacific Biosciences of California, Inc. are the major market players operating in the global tumor transcriptomics market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Tumor Type

·         Technology

·         Product

·         Application

·         End User

Regional scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Columbia; South Africa; UAE; Saudi Arabia

Key companies profiled

Thermo Fischer Scientific, Inc., Caris Life Sciences, Inc., Illumina, Inc., NanoString Technologies, Inc., 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Pacific Biosciences of California, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global tumor transcriptomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Tumor Transcriptomics Market, By Tumor Type:
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Melanoma
    • Others
  • Tumor Transcriptomics Market, By Technology:
    • Microarray
    • Real-Time Quantitative
    • Polymerase Chain Reaction (Q-PCR)
    • Others
  • Tumor Transcriptomics Market, By Product:
    • Consumables
    • Instrument
    • Software & Services
  • Tumor Transcriptomics Market, By Application:
    • Diagnostics and Disease Profiling
    • Drug Discovery
    • Others
  • Tumor Transcriptomics Market, By End User:
    • Biotechnology & Pharmaceutical Companies
    • Research & Academic Institutions
    • Others
  • Tumor Transcriptomics Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  UAE

§  Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global tumor transcriptomics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global tumor transcriptomics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Tumor Transcriptomics Market

5.    Voice of Customer

5.1.  Service Awareness

5.2.  Cancer Prevalence, By Gender

5.3.  Cancer Prevalence, By Age Group

5.4.  Cancer Prevalence, By Type

5.5.  Cancer Prevalence, By Region

5.6.  Benefits of Using Tumor Transcriptomics

5.7.  Commonly Used Technology in Tumor Transcriptomics

6.    Clinical Trial Analysis

7.    Global Tumor Transcriptomics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Tumor Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others)

7.2.2.     By Technology (Microarray, Real-Time Quantitative, Polymerase Chain Reaction (Q-PCR), Others)

7.2.3.     By Product (Consumables, Instrument, Software & Services)

7.2.4.     By Application (Diagnostics and Disease Profiling, Drug Discovery, Others)

7.2.5.     By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Others)

7.2.6.     By Company (2021)

7.2.7.     By Region

7.3.  Product Market Map

8.    North America Tumor Transcriptomics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Tumor Type

8.2.2.     By Technology

8.2.3.     By Product

8.2.4.     By Application

8.2.5.     By End User

8.2.6.     By Country

8.3.  North America: Country Analysis

8.3.1.     United States Tumor Transcriptomics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Tumor Type

8.3.1.2.2.             By Technology

8.3.1.2.3.             By Product

8.3.1.2.4.             By Application

8.3.1.2.5.             By End User

8.3.2.     Mexico Tumor Transcriptomics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Tumor Type

8.3.2.2.2.             By Technology

8.3.2.2.3.             By Product

8.3.2.2.4.             By Application

8.3.2.2.5.             By End User

8.3.3.     Canada Tumor Transcriptomics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Tumor Type

8.3.3.2.2.             By Technology

8.3.3.2.3.             By Product

8.3.3.2.4.             By Application

8.3.3.2.5.             By End User

9.    Europe Tumor Transcriptomics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Tumor Type

9.2.2.     By Technology

9.2.3.     By Product

9.2.4.     By Application

9.2.5.     By End User

9.2.6.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Tumor Transcriptomics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Tumor Type

9.3.1.2.2.             By Technology

9.3.1.2.3.             By Product

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Germany Tumor Transcriptomics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Tumor Type

9.3.2.2.2.             By Technology

9.3.2.2.3.             By Product

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     United Kingdom Tumor Transcriptomics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Tumor Type

9.3.3.2.2.             By Technology

9.3.3.2.3.             By Product

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

9.3.4.     Italy Tumor Transcriptomics Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Tumor Type

9.3.4.2.2.             By Technology

9.3.4.2.3.             By Product

9.3.4.2.4.             By Application

9.3.4.2.5.             By End User

9.3.5.     Spain Tumor Transcriptomics Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Tumor Type

9.3.5.2.2.             By Technology

9.3.5.2.3.             By Product

9.3.5.2.4.             By Application

9.3.5.2.5.             By End User

10.  Asia-Pacific Tumor Transcriptomics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Tumor Type

10.2.2.  By Technology

10.2.3.  By Product

10.2.4.  By Application

10.2.5.  By End User

10.2.6.  By Country

10.3.              Asia-Pacific: Country Analysis

10.3.1.  China Tumor Transcriptomics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Tumor Type

10.3.1.2.2.           By Technology

10.3.1.2.3.           By Product

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  India Tumor Transcriptomics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Tumor Type

10.3.2.2.2.           By Technology

10.3.2.2.3.           By Product

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  South Korea Tumor Transcriptomics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Tumor Type

10.3.3.2.2.           By Technology

10.3.3.2.3.           By Product

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

10.3.4.  Japan Tumor Transcriptomics Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Tumor Type

10.3.4.2.2.           By Technology

10.3.4.2.3.           By Product

10.3.4.2.4.           By Application

10.3.4.2.5.           By End User

10.3.5.  Australia Tumor Transcriptomics Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Tumor Type

10.3.5.2.2.           By Technology

10.3.5.2.3.           By Product

10.3.5.2.4.           By Application

10.3.5.2.5.           By End User

11.  South America Tumor Transcriptomics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Tumor Type

11.2.2.  By Technology

11.2.3.  By Product

11.2.4.  By Application

11.2.5.  By End User

11.2.6.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Tumor Transcriptomics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Tumor Type

11.3.1.2.2.           By Technology

11.3.1.2.3.           By Product

11.3.1.2.4.           By Application

11.3.1.2.5.           By End User

11.3.2.  Argentina Tumor Transcriptomics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Tumor Type

11.3.2.2.2.           By Technology

11.3.2.2.3.           By Product

11.3.2.2.4.           By Application

11.3.2.2.5.           By End User

11.3.3.  Colombia Tumor Transcriptomics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Tumor Type

11.3.3.2.2.           By Technology

11.3.3.2.3.           By Product

11.3.3.2.4.           By Application

11.3.3.2.5.           By End User

12.  Middle East and Africa Tumor Transcriptomics Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Tumor Type

12.2.2.  By Technology

12.2.3.  By Product

12.2.4.  By Application

12.2.5.  By End User

12.2.6.  By Country

12.3.              MEA: Country Analysis

12.3.1.  South Africa Tumor Transcriptomics Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Tumor Type

12.3.1.2.2.           By Technology

12.3.1.2.3.           By Product

12.3.1.2.4.           By Application

12.3.1.2.5.           By End User

12.3.2.  Saudi Arabia Tumor Transcriptomics Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Tumor Type

12.3.2.2.2.           By Technology

12.3.2.2.3.           By Product

12.3.2.2.4.           By Application

12.3.2.2.5.           By End User

12.3.3.  UAE Tumor Transcriptomics Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Tumor Type

12.3.3.2.2.           By Technology

12.3.3.2.3.           By Product

12.3.3.2.4.           By Application

12.3.3.2.5.           By End User

13.  Market Dynamics

13.1.              Drivers

13.2.              Challenges

14.  Market Trends & Developments

15.  Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

15.1.              Thermo Fischer Scientific, Inc.

15.2.              Caris Life Sciences, Inc.

15.3.              Illumina, Inc.

15.4.              NanoString Technologies, Inc.

15.5.              10x Genomics, Inc.

15.6.              Agilent Technologies, Inc.

15.7.              Bio-Rad Laboratories, Inc.

15.8.              F. Hoffmann-La Roche AG

15.9.              Fluidigm Corporation

15.10.            Pacific Biosciences of California, Inc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increased prevalence of chronic diseases and disorders worldwide and growing awareness about the benefits of personalized medicine drive the demand for the global tumor transcriptomics market.

down-arrow

Thermo Fischer Scientific, Inc., Caris Life Sciences, Inc., Illumina, Inc., NanoString Technologies, Inc., 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Pacific Biosciences of California, Inc. are the key players operating in the global tumor transcriptomics market.

down-arrow

Based on tumor type, the market is divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others. Lung cancer is expected to capture the highest market share in the forecast period.

down-arrow

The lack of skilled professionals and efficient data analysis tools in developing countries may hinder the market growth in the forecast period.

profile

Sakshi Bajaal

Business Consultant
Press Release

Tumor Transcriptomics Market to be dominated by Lung Cancer through 2027

Aug, 2022

Growing healthcare expenditure in developing countries and the rise in adoption of advanced genome sequencing tools are driving the demand for the global tumor transcriptomics market in the forecast